EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Prognostic Value of the Albumin Corrected Anion Gap in ICU Patients with Chronic Obstructive Pulmonary Disease and Sepsis: A MIMIC-IV Cohort Study

Baiquan Zhang, Jiayu Bai, Huanqin Wang, Fengxiang Huang iD, Lijun Miao iD, Jing Wang, Lu Zhou

International Journal of Chronic Obstructive Pulmonary Disease · 2025

DOI: 10.2147/copd.s544857 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2025. Verfasst von Baiquan Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Sepsis, Intensive Care Units, Acid-Base Equilibrium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China Youth Fund Project, Medical Science and Technology Research Project of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Chronic obstructive pulmonary disease (COPD) patients are at increased risk of sepsis, a condition associated with high mortality. The anion gap (AG) is commonly used to assess acid-base disturbances, but its reliability declines in hypoalbuminemia. The albumin-corrected anion gap (ACAG) may provide greater accuracy, yet its prognostic value in COPD patients with sepsis, defined according to Sepsis-3 criteria, remains unclear. Patients and Methods: This retrospective cohort study analyzed 2072 ICU patients with COPD and sepsis from the Medical Information Mart for Intensive Care IV (MIMIC-IV). Cox regression models evaluated the association between ACAG and mortality, Kaplan-Meier curves illustrated survival differences, restricted cubic splines examined nonlinear relationships, and subgroup analyses assessed consistency across strata. Receiver operating characteristic (ROC) curves compared the predictive performance of ACAG, AG, and serum albumin.

Results

Elevated ACAG was independently associated with both short- and long-term mortality. In fully adjusted models, each 1 mmol/L increase in ACAG was linked to higher risk of 28-day mortality (HR 1.064, 95% CI 1.042-1.086, P < 0.001) and 365-day mortality (HR 1.065, 95% CI 1.043-1.087, P < 0.001). A threshold effect was observed at ≥19.25 mmol/L, above which mortality risk increased markedly (28-day HR 1.336, 95% CI 1.126-1.586, P = 0.001; 365-day HR 1.429, 95% CI 1.208-1.691, P < 0.001). Kaplan-Meier survival analysis confirmed significant differences (log-rank P < 0.0001), and ROC analysis demonstrated that ACAG provided superior discrimination compared with AG and albumin for both 28-day (AUC = 0.734) and 365-day mortality (AUC = 0.696). Associations were consistent across clinical subgroups without significant interactions.

Conclusion

Elevated ACAG was an independent predictor of 28-day and 365-day all-cause mortality in critically ill patients with COPD and sepsis. An inflection point of approximately 19.25 mmol/L identified a clinically meaningful threshold for risk stratification. As a simple and widely accessible parameter, ACAG may facilitate threshold-based triage and individualized management in this high-risk population, though external validation in multicenter prospective cohorts is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveSepsisIntensive Care UnitsAcid-Base EquilibriumSerum Albumin, HumanHypoalbuminemiaSerum AlbuminHumansMaleFemaleRetrospective StudiesAgedMiddle AgedPredictive Value of TestsBiomarkersPrognosisRisk FactorsTime FactorsRisk AssessmentDatabases, FactualHospital Mortality

Stichwörter der Autor:innen

ACAGCOPDICUMIMIC-IVmortalitysepsis

Substanzen

BiomarkersSerum Albumin, HumanALB protein, humanSerum Albumin

Autor:innen und Institutionen

  • Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China.
  • The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China.

ORCID-Profile: Fengxiang Huang, Lijun Miao

Förderung

  • National Natural Science Foundation of China Youth Fund Project
  • Medical Science and Technology Research Project of Henan Province

Zitieren

APA

Zhang, B., Bai, J., Wang, H., Huang, F., Miao, L., Wang, J., & Zhou, L. (2025). Prognostic Value of the Albumin Corrected Anion Gap in ICU Patients with Chronic Obstructive Pulmonary Disease and Sepsis: A MIMIC-IV Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s544857

Vancouver

Zhang B, Bai J, Wang H, Huang F, Miao L, Wang J, et al. Prognostic Value of the Albumin Corrected Anion Gap in ICU Patients with Chronic Obstructive Pulmonary Disease and Sepsis: A MIMIC-IV Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease. 2025. doi:10.2147/copd.s544857

BibTeX
@article{Zhang2025,
  author = {Zhang, Baiquan and Bai, Jiayu and Wang, Huanqin and Huang, Fengxiang and Miao, Lijun and Wang, Jing and Zhou, Lu},
  title = {Prognostic Value of the Albumin Corrected Anion Gap in ICU Patients with Chronic Obstructive Pulmonary Disease and Sepsis: A MIMIC-IV Cohort Study},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2025},
  doi = {10.2147/copd.s544857}
}
Kostenlos starten →